. Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery. Am J Physiol Heart Circ Physiol 296: H132-H139, 2009. First published November 14, 2008 doi:10.1152/ajpheart.00370.2008.-We tested the hypothesis that hyperinsulinemia induces the suppression of protein tyrosine phosphatase 1B (PTP1B) function, leading to enhanced PDGF receptor (PDGFR) signaling and neointimal hyperplasia. Rats were implanted with insulin-releasing pellets or sham pellets. Blood glucose levels, insulin levels, food and water intake, body weights, and blood pressures were measured. Neointimal hyperplasia was assessed by computerized morphometry 14 days after carotid balloon injury. PTP1B protein expression in injured arteries was determined via Western blot analysis, whereas PTP1B activity was determined via an immunophosphatase assay. Serum insulin levels were two-to threefold greater in hyperinsulinemic rats, whereas systolic blood pressures, food and water intake, serum triglyceride levels, plasma cortisol levels, and urinary catecholamine levels were not affected. Fourteen days after injury, neointima-to-media area ratios were 0.89 Ϯ 0.23 and 1.35 Ϯ 0.22 in control and hyperinsulinemic rats, respectively (P Ͻ 0.01). PTP1B protein levels and total PTP1B activity in injured carotid arteries from the insulin-treated group were significantly decreased 7 or 14 days after injury, whereas PTP1B specific activity was decreased only 14 days after injury. These findings were associated with decreased PTP1B mRNA levels and increased PDGFR tyrosyl phosphorylation in insulin-treated rats. These observations support the hypothesis that hyperinsulinemia induces the suppression of PTP1B function, leading to enhanced PDGFR signaling and neointimal hyperplasia. restenosis; reverse transcription-polymerase chain reaction; vascular injury; protein tyrosine phosphatase 1B; platelet-derived growth factor HYPERINSULINEMIA is a key feature of metabolic syndrome and type 2 diabetes (18). Moreover, plasma insulin levels in the population of the United States appear to have increased by ϳ35% during the last decade (32). It is now well accepted that metabolic syndrome and type 2 diabetes are strongly associated with adverse cardiovascular events in humans, although the underlying reasons for these associations have not been clarified (3,12,44,49,55). Several recent studies have reported that hyperinsulinemia is associated with vascular remodeling and enhanced neointima formation in models of experimental vascular injury as well as in humans (20,28,37,39,55). Moreover, hyperinsulinemia, but not hyperglycemia, has been reported to induce enhanced neointima formation in models of rat vascular injury (11, 28).The migration of medial vascular smooth muscle cells to the intima and the subsequent cell proliferation are thought to be necessary for the vascular remodeling that occurs after injury or in atherosclerosis. Acute treatment with insulin has been reported to atte...